Book contents
- Frontmatter
- Contents
- List of contributors
- Series Editor's Preface
- Abbreviations
- 1 Resistance mechanisms to antimetabolites
- 2 Resistance to antitumor alkylating agents and cisplatin
- 3 The MDR genes
- 4 Topoisomerase genes and resistance to topoisomerase inhibitors
- 5 Genes that modulate apoptosis: major determinants of drug resistance
- 6 Clinical implications of drug resistance
- 7 The reversal of multidrug resistance
- 8 Effect of dose and schedule on chemotherapeutic drug resistance
- 9 Circumvention of drug resistance by high-dose chemotherapy in solid tumors
- 10 Enhancing drug effectiveness by gene transfer
- Index
Frontmatter
Published online by Cambridge University Press: 14 October 2009
- Frontmatter
- Contents
- List of contributors
- Series Editor's Preface
- Abbreviations
- 1 Resistance mechanisms to antimetabolites
- 2 Resistance to antitumor alkylating agents and cisplatin
- 3 The MDR genes
- 4 Topoisomerase genes and resistance to topoisomerase inhibitors
- 5 Genes that modulate apoptosis: major determinants of drug resistance
- 6 Clinical implications of drug resistance
- 7 The reversal of multidrug resistance
- 8 Effect of dose and schedule on chemotherapeutic drug resistance
- 9 Circumvention of drug resistance by high-dose chemotherapy in solid tumors
- 10 Enhancing drug effectiveness by gene transfer
- Index
Summary
![Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'](https://static.cambridge.org/content/id/urn%3Acambridge.org%3Aid%3Abook%3A9780511526992/resource/name/firstPage-9780511526992pre_pi-vi_CBO.jpg)
- Type
- Chapter
- Information
- Drug Resistance in the Treatment of Cancer , pp. i - viPublisher: Cambridge University PressPrint publication year: 1998